Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-22 4:05 pm Purchase |
2024-08-20 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences Public Fund, L.P. | 12,788,710 18.000% |
2,618,922 (+25.75%) |
Filing |
| 2024-06-06 1:59 pm Purchase |
2024-03-07 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences Public Fund, L.P. | 10,169,788 17.400% |
44,000 (+0.43%) |
Filing |
| 2023-05-26 5:29 pm Purchase |
2023-05-24 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences Public Fund, L.P. | 10,125,788 18.500% |
1,697,683 (+20.14%) |
Filing |
| 2023-05-05 4:13 pm Purchase |
2023-04-13 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences Public Fund, L.P. | 8,428,105 19.300% |
8,428,105 (New Position) |
Filing |